GO:0008065 establishment of blood-nerve barrier: Barrier Assembly, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008065 describes the establishment of the diffusion barrier between the perineurium of peripheral nerves and the vascular endothelium of endoneurial capillaries.
• The blood-nerve barrier (BNB) is a specialized interface that protects the peripheral nerve microenvironment and maintains ion homeostasis.
• The BNB is formed by tight junctions between endoneurial endothelial cells and the perineurial cell layers, and its establishment is developmentally regulated.
• Disruption of the BNB is a key pathophysiological event in immune-mediated peripheral neuropathies such as Guillain-Barré syndrome and CIDP.
• The BNB is more permeable to ions than the blood-brain barrier, but still restricts macromolecules and immune cells.
• Understanding BNB establishment informs therapeutic strategies for peripheral neuropathies and nerve regeneration.
Description
The establishment of the blood-nerve barrier (BNB) is a critical developmental process that creates a selective interface between the peripheral nerve microenvironment and the systemic circulation. This barrier is essential for maintaining the homeostasis required for proper nerve conduction and protecting peripheral nerves from blood-borne toxins and immune cells. The BNB is composed of two main cellular components: the perineurial cell layers that surround the nerve fascicles and the endoneurial vascular endothelium that forms the blood-nerve interface. The establishment of this barrier involves the coordinated formation of tight junctions, the expression of specialized transporters, and the maturation of the perineurial diffusion barrier. Researchers study GO:0008065 to understand peripheral nerve development, the pathogenesis of immune-mediated neuropathies, and to develop strategies for drug delivery to peripheral nerves. The BNB is distinct from the blood-brain barrier in its permeability properties, being more permeable to ions while still restricting macromolecules. This unique property allows for the maintenance of the endoneurial ionic environment necessary for nerve excitability.
establishment of blood-nerve barrier At A Glance
| GO ID | GO:0008065 |
|---|---|
| GO term | establishment of blood-nerve barrier |
| Ontology | biological_process |
| Synonym | establishment of blood/nerve barrier |
| Major function | Formation of a selective diffusion barrier between peripheral nerve endoneurial capillaries and the perineurium |
| Cellular components | Endoneurial endothelial cells, perineurial cells, tight junctions |
| Developmental timing | Postnatal maturation in rodents, with barrier properties increasing after birth |
| Permeability | Higher ion permeability than blood-brain barrier but restricts macromolecules |
| Related disorders | Guillain-Barré syndrome, CIDP, diabetic neuropathy |
What Is GO:0008065?
GO:0008065, establishment of blood-nerve barrier, is defined as the developmental process that creates the barrier between the perineurium of peripheral nerves and the vascular endothelium of endoneurial capillaries. The perineurium acts as a diffusion barrier, but ion permeability at the blood-nerve barrier is higher than at the blood-brain barrier. This process involves the formation of tight junctions between endothelial cells and the maturation of perineurial cell layers to restrict paracellular transport.
Why Is establishment of blood-nerve barrier Important in Cell Biology?
The establishment of the blood-nerve barrier is fundamental for peripheral nerve function and protection. It maintains the specialized endoneurial environment necessary for efficient nerve impulse conduction and shields nerve fibers from circulating toxins, pathogens, and immune cells. Disruption of this barrier is a hallmark of immune-mediated peripheral neuropathies, where breakdown allows immune cell infiltration and subsequent demyelination or axonal damage. Understanding the molecular mechanisms of BNB establishment can reveal therapeutic targets for preventing or repairing barrier dysfunction in diseases such as Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
• Maintains endoneurial ion homeostasis required for nerve conduction.
• Protects peripheral nerves from blood-borne toxins and pathogens.
• Prevents autoimmune attack by restricting immune cell entry into nerve tissue.
• Its breakdown is a key event in Guillain-Barré syndrome and CIDP.
• Plays a role in nerve regeneration and repair after injury.
• Influences drug delivery to peripheral nerves and therapeutic efficacy.
• Developmental studies reveal critical windows for barrier maturation.
• Provides a model for understanding barrier biology beyond the blood-brain barrier.
• Dysfunction contributes to diabetic neuropathy and other metabolic neuropathies.
• Targeting BNB components may offer new treatments for peripheral neuropathies.
What Happens During establishment of blood-nerve barrier?
Formation of the perineurial diffusion barrier
In simple terms: The outer sheath of the nerve becomes a tight seal that blocks most substances from leaking in.
The perineurium, composed of concentric layers of perineurial cells, develops tight junctions that restrict paracellular diffusion. This process begins during late embryonic development and continues postnatally, with the perineurial barrier becoming fully functional in the first weeks after birth in rodents. The perineurial cells express tight junction proteins such as claudins and occludin, which seal the intercellular spaces.
Maturation of endoneurial endothelial tight junctions
In simple terms: The blood vessels inside the nerve become less leaky by forming tight connections between their cells.
Endoneurial endothelial cells form tight junctions that limit the passage of macromolecules and immune cells from the blood into the nerve. This maturation involves the upregulation of tight junction proteins and the establishment of a high electrical resistance across the endothelial layer. The process is regulated by interactions with pericytes and the surrounding nerve environment.
Development of selective permeability
In simple terms: The barrier allows some ions to pass while blocking larger molecules, creating a unique environment.
Unlike the blood-brain barrier, the blood-nerve barrier exhibits higher ion permeability, which is essential for maintaining the endoneurial ionic composition necessary for nerve excitability. This selective permeability is achieved through the expression of specific ion channels and transporters on endothelial and perineurial cells. The barrier also actively transports nutrients and removes waste products.
Postnatal maturation and stabilization
In simple terms: The barrier continues to strengthen after birth and becomes fully functional over time.
In neonatal rats, the blood-nerve barrier is initially leaky and gradually becomes impermeable to macromolecules over the first few weeks of life. This maturation is accompanied by changes in the expression of tight junction proteins and the deposition of extracellular matrix components. The stabilization of the barrier is critical for protecting the developing nerve from immune-mediated damage.
Key Genes Involved in GO:0008065 establishment of blood-nerve barrier
The following genes and proteins are key players in the establishment and function of the blood-nerve barrier, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CLDN5 | Tight junction protein in endothelial cells | Regulates paracellular permeability at the BNB |
| OCLN | Tight junction protein | Essential for barrier integrity |
| TJP1 | Scaffolding protein at tight junctions | Links tight junction proteins to the cytoskeleton |
| CDH5 | Endothelial adherens junction protein | Maintains endothelial cell-cell adhesion |
| SLC2A1 | Glucose transporter | Facilitates nutrient transport across the BNB |
| ABCB1 | Efflux transporter | Protects nerve from xenobiotics |
| LAMA2 | Extracellular matrix protein | Supports perineurial cell organization |
| COL4A1 | Basement membrane component | Provides structural support to the barrier |
| ITGB1 | Integrin subunit | Mediates cell-matrix interactions in perineurial cells |
| VEGFA | Angiogenic factor | Regulates endothelial permeability and barrier development |
| ANGPT1 | Angiopoietin | Stabilizes endothelial junctions |
| PDGFB | Growth factor | Recruits pericytes to endoneurial vessels |
| NOTCH3 | Receptor in pericytes | Regulates pericyte differentiation and barrier function |
| S1PR1 | Sphingosine-1-phosphate receptor | Modulates endothelial barrier integrity |
| ICAM1 | Adhesion molecule | Mediates immune cell adhesion during barrier breakdown |
| MMP9 | Matrix metalloproteinase | Degrades basement membrane during neuroinflammation |
| TNF | Pro-inflammatory cytokine | Increases barrier permeability in neuropathies |
How Is establishment of blood-nerve barrier Regulated?
The establishment of the blood-nerve barrier is regulated by a complex interplay of developmental signals, transcription factors, and extracellular cues. Tight junction assembly is controlled by the expression of claudins and occludin, which are regulated by transcription factors such as Snail and Slug. Angiogenic factors like VEGFA and ANGPT1 modulate endothelial permeability and junction stability during barrier formation. Pericyte recruitment via PDGFB and NOTCH3 signaling is essential for endothelial maturation and barrier integrity. Inflammatory cytokines such as TNF can disrupt barrier function by downregulating tight junction proteins, a mechanism relevant to immune-mediated neuropathies. Additionally, sphingosine-1-phosphate signaling through S1PR1 regulates endothelial barrier function and lymphocyte egress.
establishment of blood-nerve barrier and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CLDN5 | Guillain-Barré syndrome, barrier permeability | Endothelial-specific knockout mouse |
| TNF | Neuroinflammation, CIDP | TNF overexpression in nerve tissue |
| MMP9 | Barrier breakdown in neuropathy | MMP9 knockout mouse |
| S1PR1 | Immune cell infiltration in neuropathies | Conditional knockout in endothelium |
| VEGFA | Altered angiogenesis and permeability | Inducible overexpression in nerve |
Guillain-Barré syndrome and CIDP
In immune-mediated peripheral neuropathies such as Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP), breakdown of the blood-nerve barrier allows circulating immune cells and autoantibodies to enter the endoneurial space, leading to demyelination and axonal damage. The loss of tight junction integrity and increased permeability are key pathological features. Therapies targeting the BNB, such as intravenous immunoglobulin and corticosteroids, aim to restore barrier function.
Diabetic neuropathy
Diabetes mellitus can impair blood-nerve barrier function through hyperglycemia-induced oxidative stress and inflammation, contributing to nerve dysfunction. Studies have shown increased permeability and altered tight junction protein expression in diabetic nerves. Maintaining BNB integrity is a potential therapeutic strategy for diabetic neuropathy.
Nerve injury and regeneration
After peripheral nerve injury, the blood-nerve barrier is disrupted, allowing macrophages and other immune cells to enter and clear debris. However, excessive or prolonged barrier breakdown can impair regeneration. Understanding how the barrier is re-established after injury is important for developing therapies to promote nerve repair.
From establishment of blood-nerve barrier-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate tight junction formation? | Endothelial-specific knockout of gene X in mice |
| Does a point mutation in CLDN5 affect barrier permeability? | Knock-in mouse expressing mutant CLDN5 |
| Can we visualize BNB establishment in vivo? | Tagged knock-in of tight junction proteins with fluorescent reporters |
| Does overexpression of VEGFA disrupt the BNB? | Inducible overexpression of VEGFA in peripheral nerve |
| What is the role of perineurial cells in barrier function? | Perineurial cell-specific knockout of candidate genes |
| How does inflammation affect BNB integrity? | TNF overexpression or LPS-induced inflammation models |
How to Study the establishment of blood-nerve barrier Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Evans blue extravasation | Barrier permeability to macromolecules | Assessing BNB integrity in vivo |
| Immunofluorescence | Expression and localization of tight junction proteins | Visualizing BNB structure |
| Transmission electron microscopy | Ultrastructure of tight junctions | Confirming barrier formation |
| RNA-seq | Transcriptional profile of barrier cells | Identifying novel regulators |
| Proteomics | Protein composition of barrier cells | Discovering barrier-specific proteins |
| TEER measurement | Electrical resistance of cell monolayers | In vitro barrier models |
| Flow cytometry | Immune cell infiltration into nerves | Assessing barrier breakdown |
| Western blot | Protein expression levels | Quantifying tight junction proteins |
Tracer permeability assays
The integrity of the blood-nerve barrier can be assessed by intravenous injection of tracers such as Evans blue albumin or fluorescent dextrans, followed by quantification of tracer extravasation into the endoneurial space. This method provides a direct measure of barrier permeability in vivo.
Immunohistochemistry and confocal imaging
Immunostaining for tight junction proteins (e.g., claudin-5, occludin, ZO-1) and endothelial markers allows visualization of barrier structure and integrity in nerve sections. Confocal microscopy can reveal co-localization and morphological changes in the BNB.
Electron microscopy
Transmission electron microscopy can visualize tight junctions between endothelial cells and perineurial cells at ultrastructural resolution, confirming barrier formation. This technique is valuable for assessing junctional complexity and integrity.
Transcriptomic and proteomic profiling
RNA sequencing and mass spectrometry of isolated endoneurial vessels or perineurial cells can identify genes and proteins involved in BNB establishment and maintenance. These approaches can reveal novel regulators and biomarkers.
How CRISPR Can Be Used to Study GO:0008065 establishment of blood-nerve barrier
Knockout
CRISPR knockout of genes such as CLDN5 or OCLN in endothelial cells or mouse models can determine their essential roles in blood-nerve barrier establishment. Knockout studies have shown that loss of tight junction proteins leads to increased permeability and nerve dysfunction.
Point Mutation
Introducing point mutations in tight junction genes (e.g., CLDN5) can mimic human variants or disrupt specific protein interactions, allowing researchers to study the impact on barrier function. Such models are valuable for understanding structure-function relationships.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous tight junction genes enables real-time visualization of barrier formation and dynamics in live animals. This approach can reveal when and where barrier components are expressed during development.
Overexpression
Overexpression of barrier-disrupting factors such as VEGFA or TNF using CRISPR activation or transgenic approaches can induce barrier breakdown, modeling neuroinflammatory conditions. Conversely, overexpression of protective factors can enhance barrier integrity.
How EDITGENE Supports establishment of blood-nerve barrier Research
Researchers studying establishment of blood-nerve barrier-related genes often need to determine whether a candidate gene is causally involved in barrier formation, maintenance, or disruption. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for establishment of blood-nerve barrier research.
Frequently Asked Questions About establishment of blood-nerve barrier
What is the establishment of blood-nerve barrier?
It is the developmental process that forms the selective barrier between the perineurium of peripheral nerves and the vascular endothelium of endoneurial capillaries, as defined by GO:0008065.
What genes are involved in the establishment of blood-nerve barrier?
Key genes include CLDN5, OCLN, TJP1, CDH5, and SLC2A1, which encode tight junction proteins, adhesion molecules, and transporters critical for barrier function.
What is the function of the blood-nerve barrier?
The blood-nerve barrier protects peripheral nerves from blood-borne toxins and immune cells while maintaining the specialized endoneurial ionic environment necessary for nerve conduction.
How is the blood-nerve barrier different from the blood-brain barrier?
The blood-nerve barrier has higher ion permeability than the blood-brain barrier but still restricts macromolecules, reflecting its unique role in peripheral nerve homeostasis.
What diseases are associated with blood-nerve barrier dysfunction?
Disruption of the blood-nerve barrier is implicated in Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and diabetic neuropathy.
When does the blood-nerve barrier develop?
In rodents, the blood-nerve barrier matures postnatally, becoming fully functional over the first few weeks after birth.
How can I study the blood-nerve barrier in the lab?
Common methods include tracer permeability assays, immunohistochemistry for tight junction proteins, electron microscopy, and transcriptomic profiling of endoneurial vessels.
What CRISPR models are available for blood-nerve barrier research?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes like CLDN5, OCLN, and VEGFA to study barrier function.
What is the role of perineurial cells in the blood-nerve barrier?
Perineurial cells form concentric layers with tight junctions that act as a diffusion barrier, complementing the endothelial barrier.
Can the blood-nerve barrier be targeted for drug delivery?
Yes, understanding BNB permeability and transport mechanisms can inform strategies to enhance drug delivery to peripheral nerves.
Conclusion
The establishment of the blood-nerve barrier (GO:0008065) is a vital developmental process that creates a selective interface protecting peripheral nerves and maintaining their specialized microenvironment. Its disruption is central to the pathogenesis of immune-mediated and metabolic neuropathies, making it a key area of research. Advances in CRISPR-based models and imaging techniques continue to unravel the molecular players and regulatory networks involved. Targeting the blood-nerve barrier holds promise for novel therapies aimed at restoring barrier function and treating peripheral neuropathies.
References
- 1. Stubbs EB Jr. 2020. Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.. Exp Neurol 331:113385 PMID: 32562668
- 4. Kanda T. 2013. Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies.. J Neurol Neurosurg Psychiatry 84(2):208-12 PMID: 23243216
- 7. Kanda T. 2009. [Peripheral neuropathy and blood-nerve barrier].. Rinsho Shinkeigaku 49(11):959-62 PMID: 20030260
- 8. Smith CE et al.. 2001. Development of the blood-nerve barrier in neonatal rats.. Microsurgery 21(7):290-7 PMID: 11754428
